COMMUNIQUÉS West-GlobeNewswire

Ossur Hf : Transactions in relation to share buyback program
04/12/2017
Announcement from Össur hf. No. 85/2017 Reykjavík, 4 December 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
Genmab to Hold 2017 R&D Update
04/12/2017
Media Release R&D Update to be held live in Atlanta, Georgia Key Opinion Leaders to discuss daratumumab and tisotumab vedotin data Discussion of Genmab’s pipeline, 2017 progress & company goals for 2018 Meeting [...]
NAPA’s Dorina Leibu Named to Board of American Health Council
04/12/2017
MELVILLE, N.Y., Dec. 04, 2017 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) announced today that the American Health Council has elected Dorina Leibu, MD to its physician board. Dr. Leibu, an [...]
Olainfarm Goes on a Road Show to Baltic, Nordic and Polish Investors
04/12/2017
Olaine, 2017-12-04 16:03 CET (GLOBE NEWSWIRE) -- Meetings are planned on December 5 in Warsaw, December 6 in Stockholm, December 7 in Helsinki, December 8 in Tallinn and December 11 in Vilnius. More than 20 meetings [...]
Internal CRA documents show intent to deny the disability tax credit to Canadians with type 1 diabetes
04/12/2017
OTTAWA, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Diabetes Canada and JDRF join today in expressing disappointment after receiving a copy of an internal Canada Revenue Agency (CRA) email demonstrating that a decision was made [...]
Des documents internes de l’ARC démontrent l’intention de refuser aux Canadiens atteints de diabète de type 1 l’accès au crédit d’impôt pour personnes handicapées
04/12/2017
OTTAWA, 04 déc. 2017 (GLOBE NEWSWIRE) -- Diabète Canada et FRDJ désirent exprimer conjointement leur déception après avoir reçu copie d’un courriel interne de l’Agence du revenu du Canada (ARC) qui démontre qu’une [...]
Vascular Dynamics Appoints Ed Roschak CEO
04/12/2017
MOUNTAIN VIEW, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc. (VDI), a privately held medical device company which has developed an innovative treatment system for the treatment of hypertension, today [...]
Radius Health Announces Five Presentations on elacestrant (RAD1901) at the San Antonio Breast Cancer Symposium (SABCS)
04/12/2017
SABCS to include five abstracts from the development program for elacestrant as a potential treatment of ER-positive advanced breast cancer Radius to host live webcast to discuss data presented at SABCS and provide a [...]
La Jolla Pharmaceutical Company Announces Initiation of Pivotal Clinical Study of LJPC‑401 in Patients with Beta Thalassemia
04/12/2017
SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (NASDAQ: LJPC ) (the Company or La Jolla) today announced the initiation of a pivotal clinical study of LJPC‑401 (synthetic human hepcidin) in [...]
Teladoc Adds New Health System Clients, Achieving 2017 Growth in Excess of 100%
04/12/2017
PURCHASE, NY, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ) the world’s largest and most trusted provider of virtual care delivery services, today announced record growth of greater than 100% in the [...]
Marrone Bio Innovations Adds Three Commercial Managers for Southeast, West Coast, and Northeast and Mid-Atlantic Regions
04/12/2017
DAVIS, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental [...]
Novelion Therapeutics Appoints Michael Price as Senior Vice President and Chief Financial Officer
04/12/2017
VANCOUVER, British Columbia, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]
Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel Deaconess Medical Center, to Develop CRISPR/Cas9-Enhanced CAR T Therapies
04/12/2017
NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
FDA Selects HemoStyp® for CtQ Pilot Program
04/12/2017
HENDERSON, Nev., Dec. 04, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]
Uptick Newswire “Stock Day” Interviews CEO of Progressive Care on the Completed Success in the Pharmaceutical Industry
04/12/2017
Miami, FL , Dec. 04, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire “Stock Day” host Everett Jolly warmly welcomes back a long awaited guest Shital Mars, CEO of Progressive Care Inc. (OTCPink: RXMD) (“Progressive Care” or the [...]
Canadian Blood Services board meeting open to the public
04/12/2017
OTTAWA, Dec. 04, 2017 (GLOBE NEWSWIRE) -- On Dec. 7, Canadian Blood Services will open its doors physically and virtually, by live streaming its open board meeting at blood.ca, and inviting the public to attend in [...]
La réunion du conseil d’administration de la Société canadienne du sang ouverte au public
04/12/2017
OTTAWA, 04 déc. 2017 (GLOBE NEWSWIRE) -- La Société canadienne du sang invite la population à assister, en personne ou en ligne, à la réunion de son conseil d’administration. La réunion aura lieu le 7 décembre à Ottawa [...]
CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel
04/12/2017
NEWARK, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel
04/12/2017
NEWARK, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Pages